|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o BioMarin Pharmaceutical Inc., of Novato, Calif., said it intends to offer $250 million worth of senior subordinated convertible notes due 2017 in an underwritten public offering, and will grant underwriters a 13-day option to purchase up to an additional $37.5 million of notes to cover overallotments. Merrill Lynch & Co., of New York, is acting as sole book-running manager of the public offering.
o BioTrove Inc., of Woburn, Mass., said researchers at the Center of Molecular Orthopedics at Harvard Medical School and the Department of Orthopedics at Brigham & Women's Hospital will investigate human cellular response to chemical weapons, as well as adult stem cell ...
Related newspaper, magazine, and journal articles:
|
|
Article: Sartorius Stedim Biotech Acquires Wave Biotech AG.
Business Wire;
October 31, 2008 ;
700+ words
... ... the Swiss-based technology company Wave Biotech AG. Both companies have already been ... Stedim Biotech, about the acquisition. Wave Biotech AG is among the globally leading companies ... costs for cleaning and validation. Wave Biotech AG is based in Tagelswangen near Zurich ...
|
|